DxTerity Announces Preliminary Results from the BRAVO Study will be Presented at the 2017 ACR/ARHP Annual Meeting

LOS ANGELES, Nov. 5, 2017 /PRNewswire/ -- DxTerity, a patient-centric genomics company developing at-home genomic monitoring blood tests for immune mediated diseases, today announced that data on the BRAVO Study in which participants with rheumatoid arthritis (RA) used a combination of...